ANCP: Prevention and care for drug-resistant tuberculosis in Myanmar
Past project
This project aims to implement and evaluate a model of community-based drug-resistant tuberculosis care to facilitate scale-up in Myanmar and other similar resource-constrained settings.
Objective
Key objectives are to:
- build the capacity of township health system in delivering and co-ordinating MDR-TB prevention and care
- deliver quality community-based MDR-TB prevention and care services through community-based treatment supporters
- improve community and health facility-based TB/MDR-TB infection control, TB preventative activities and education
- measure the impact, effectiveness and feasibility of the model of care through monitoring and evaluation and operational research.
Timeline
July 2014–June 2018.
Approach
The project, supported by the Australian NGO Cooperation Agreement Program, Department of Foreign Affairs and Trade (ANCP-DFAT) is:
- providing all 60 existing multidrug-resistant TB (MDR-TB) patients with treatment support for at least nine months of the first year
- reducing the burden on the health system and enabling treatment and care for more MDR-TB patients diagnosed but not currently enrolled.
Partners
- Township Medical Authority, South Dagon, Yangon Division
- National Tuberculosis Program, Central and Zonal
- Myanmar Mothers and Children Welfare Association
- Myanmar Red Cross Society
- Add
Project contacts
Project team
Associate Professor Suman Majumdar
Chief Health Officer - COVID & Health Emergencies; Deputy Program Director, Health Security and Pandemic Preparedness; Principal Research Fellow
Naanki Pasricha
Senior Manager, Strategy and Engagement
